🔸 Are You Stuck Here? 🔸
You have a good product, yet growth has slowed, adoption feels unpredictable, and the team is working harder without seeing the same results. The more tools and meetings you add, the more progress seems to stall between idea and delivery. It is frustrating to watch promising ideas lose momentum before they reach the customer.

🔸 There Is a Better Way 🔸
Most teams try to fix these symptoms with more process. What actually needs repair is the holistic product experience. I believe growth-stage companies win when they build experiences that work for customers and the business. That is the work of Product Experience Architecture. I help teams shorten the time from idea to validated impact by crafting products customers love and businesses trust.

🔸 My 3 Step Plan for Your Success 🔸
Through the PX360 Builder Advantage, I help growth-stage teams turn product development complexity into clarity, connection, and measurable results.
1️⃣ Diagnose Friction: We uncover where poor product experience (external and internal) is negatively impacting flow so teams can move with purpose.
2️⃣ Align the Builders: We connect product management, design, and engineering to buyer and user goals and outcomes.
3️⃣ Accelerate Impact: We shorten the idea-to-impact cycle and translate product work into adoption and growth.

🔸 Proof This Works 🔸
I have used this framework with HealthTech, FinTech, and EdTech leaders to replace stalled launches with real momentum. Many see adoption gains within 60 to 90 days. My background in product strategy and delivery taught me that when clarity leads, impact follows. Because this work is deep and collaborative, I partner with a limited number of companies each quarter who are ready to build differently, not just faster.

🔸 Your Next Step Is Clear 🔸
If you want to leverage product experience to drive customer and business outcomes, let’s talk. I offer a 30-minute Product Experience Clarity Session to pinpoint where friction hides between idea and impact. This is a working session, not a sales call. You will leave with clear insights whether we work together or not.

➥ Book your session: https://cal.com/natemjones/clarity-session

Nate Jones

Go work with Roth LaFleur! He’s a Product leader that truly cares about users and understands that great teams built amazing products.

Crafting product experiences that hold up when users, buyers, and boards look closely | Product Experience Architect | HealthTech • FinTech • EdTech | Fractional & Advisory

We are your omni know-how experts – delivering data-driven engagement and omnichannel activation for your targeted health care audiences, with local impact and national scale to meet the needs of your brand.

Elsevier

Elsevier is an information analytics company with expertise in improving clinical workflows and reducing unwarranted variability in care through our oncology clinical decision support software, ClinicalPath. As a Product Manager I engage in new product development and lead strategic initiatives to expand our product offerings across the US and internationally.  I also lead a Scrum team to develop and deploy enhancements to our pathway algorithm authoring platform. I am currently focusing on new features to reduce the maintenance burden for our content authors and hospital system customers to manage their clinical trial libraries and increase trial screenings/accruals.

Product Manager

As a Content Principal I work in cross functional teams to develop new commercializable software features and drive the expansion of ClinicalPath into international markets. I lead market and customer discovery research to deliver strategic product recommendations to senior leadership and act as an internal consultant for international teams to provide guidance on content development, authoring workflows, and feature requirements.

Principal, ClinicalPath Content

As a senior clinical content analyst, I provided content support of new commercial initiatives, developed and managed relationships with external partners, led internal process improvement initiatives, and served as a cultural role model. I worked closely with customers, key opinion leaders, and our internal teams to define and deliver new product offerings that support the workflow and decision making of oncology health professionals. I led the development of clinical content in our product that will simplify the prior authorization burden and embedded national oncology guidelines within our proprietary decision support algorithms.

Senior Clinical Content Analyst

As an intermediate clinical content analyst, I developed and built new clinical decision support pathways to expand the ClinicalPath product into new markets. I worked in a matrix with physicians, pharmacists, product managers, information technologists, and UX designers to perform customer discovery, build and develop new decision support software tools, and test prototypes with end users.

Intermediate Clinical Content Analyst

The ClinicalPath evidence-based algorithms are collaboratively developed by disease committees of physicians from within the ClinicalPath Network to help oncologists deliver standardized care while controlling costs. As an associate clinical content analyst, I planned and executed regular disease committee meetings for medical and radiation oncology modalities. By managing the disease committees, I built relationships with key opinion leaders in academic and community medical centers to drove to evidence-based consensus on optimal standards of care for distinct patient populations. I reviewed recent clinical trial data to evaluate potential impacts to the current standard of care and authored software updates to incorporate changes to treatment recommendations. I managed asynchronous timelines for numerous disease pathways while adhering to strict documentation and quality assurance protocols.

Associate Clinical Content Analyst

sciVelo

The Pittsburgh Health Data Alliance’s Center for Commercial Applications of Healthcare Data guides early stage research toward clinical and commercial translation through technology licensing and new company formation. As a Senior Commercial Translation Associate I provided commercial project management to early stage AI/ML digital health technologies and served as the communications focal point between the project team, university administrators, the project sponsor, and potential technology licensees. This included moderating regular check-in meetings, tracking progress against deliverable milestones, monitoring for public disclosures that may jeopardize intellectual property, proactively identifying and removing roadblocks, and facilitating contract amendments as needed. I also worked closely with the inventors and sponsors to determine the best approach for a smooth transition into a commercial translation receptor (licensing, new company formation) or to prepare the team to pursue additional funding for continued product and business plan development. 

I’ve advised dozens of investigators on their commercial translation options and early IP protection steps, coached 5 teams to develop and deliver funding pitches to potential industry sponsors, and oversaw the due diligence, contracting, and on-going project management of 3 technologies that are actively developing new digital health solutions with industry funding. With my leadership the university has secured nearly $1.5 M in commercial translation funding resulting in 5 new licensable invention disclosures. 

I additionally supported sciVelo strategic initiatives, including developing invention disclosures for early stage research, mentoring junior associates to gain differentiated business and leadership skills, and leading the collaborative development our our guiding purpose statement and core values.

Senior Commercial Translation Associate

As a commercial translation associate, I lead teams of researchers with prospective digital health technologies through the commercialization process to secure intellectual property, assess the market space and regulatory hurdles, raise funding, and construct their commercialization strategy. My projects focus on the development of clinical decision support tools and predictive analytics in healthcare using machine learning and natural language processing to provide actionable recommendations based on PROs, EHR records, biological data, publicly available data repositories, voice recordings, and other data sources.

Commercial Translation Associate

Fourth River Solutions

Fourth River Solutions is a not for profit consulting organization allowing scientific trainees to develop professional skills through experiential learning engagements. Consultants leverage their critical thinking expertise to provide impact and value to our clients. 

In my roles I have:
•	Managed Google Enterprise infrastructure and established SOPs to support 85 active consultants
•	Planned and executed on-boarding of 30 new consultants in 2 cohorts, including leading classroom lectures and providing hands-on coaching to trainees in their first engagement 
•	Developed business plan with team of 5 consultants to bring new medical device to market including market sizing, competitive analysis, patent landscape, regulatory hurdles, reimbursement, and exit strategies

Chief Operating Officer

Project Manager

Consultant

University of Pittsburgh

Conducted research on the therapeutic potential of ion transporter inhibiters in glioblastoma multiforme 

Composed grants, manuscripts, and protocols spanning 4 research projects leading to 2 first author publications 

Managed laboratory operations including writing progress reports for 4 NIH/VA grants, negotiating pricing, monitoring budgets, maintaining inventories, and liaising with EH&S and IACUC inspectors 

Supervised and mentored 10 undergraduates and junior lab members to develop hypotheses, conduct rigorous experiments, communicate scientific ideas, perform statistical analyses, and work safely in the lab

Postdoctoral Research Associate

University of Bordeaux-INSERM U862

Oliet Lab
Utilized mass spectrometry to identify novel perisynaptic astrocyte proteins involved in various behavioral models of synaptic plasticity. Research was conducted in conjunction with the VU University Amsterdam.

PhD Student

Vrije University Amsterdam-Center for Neurogenomics and Cognitive Research (CNCR)

Smit/Verheijen Lab
Utilized mass spectrometry to identify novel perisynaptic astrocyte proteins involved in various behavioral models of synaptic plasticity. Research was conducted in conjunction with the University of Bordeaux/Inserm U862

PhD student

Vrije Universiteit

Teaching Assistant

Charité

Heppner Lab

Project established baselines to examine microglia mediated changes in neurogenesis associated gene expression in the mouse hippocampus under environmental enrichment. Gene expression, cell survival, cell proliferation, and microglia coverage were analyzed in WT mice housed in standard and enriched cages. These were compared with transgenic mice in normal and enriched environments after conditional ablation of microglia to evaluate the role of microglia in neurogenesis.

Research Intern

University of Groningen

Eggen Lab

Research induced two single nucleotide polymorphisms (SNPs) into UTF1, a gene involved in proper stem cell differentiation. Mutations were cloned into murine stem cells and effects on protein functionality were evaluated.

Eckerd College

Flaherty Lab

Project combined techniques of overexpression and RNAi in C. elegans directed at the MAP protein tau to model the neurodegeneration seen in Alzheimer’s disease.

I’m passionate about applying data and technology to solve our most pressing healthcare problems. I leverage my academic and industry experiences to bridge the gaps between clinicians, data scientists, and business development partners to bring new digital health technologies to market. I love working at the intersection of science and business to ensure we are asking the right questions and developing implementable healthcare solutions for the patients who need them most.

As a Product Manager at Elsevier, I work collaboratively with an international, cross-functional team of UX, Software Engineering, Digital Content, and Commercial stakeholders to improve and expand our oncology-focused clinical decision support tool, ClinicalPath. I lead a Scrum team focused on our proprietary clinical algorithm authoring platform, called PathBuildR, which allows us to construct computer interpretatable pathways. In this role I balance on-time delivery of new revenue driving functionality with usability improvements to enhance the day-to-day experience of internal users.


Knowledge areas: product management, product owner, agile methodology, clinical pathways, clinical decision support, clinical workflows, digital health, oncology, neuroscience, project management, product roadmaps, customer discovery, market research, competitive analyses, academic commercial translation, pitch development, business development, strategic partnerships, intellectual property, leadership, mentoring, professional branding, oral presentations

taplio

The Battle

Nate Jones

Karen Carney, PhD

Followers

Posts

Engagements

Likes

Performance ScoreNate Jones's LinkedIn Performance

Ready to grow your LinkedIn presence?

taplio

The Battle

Nate Jones

Karen Carney, PhD

Followers

Posts

Engagements

Likes

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}Nate Jones's LinkedIn Performance

Ready to grow your LinkedIn presence?

Performance ScoreNate Jones's LinkedIn Performance